We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+1.17%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$406M
AUM Growth
+$71.8M
Cap. Flow
+$62M
Cap. Flow %
15.25%
Top 10 Hldgs %
55.4%
Holding
62
New
16
Increased
17
Reduced
12
Closed
17

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$19.9M
2
ABCL icon
AbCellera Biologics
ABCL
+$18.6M
3
DXCM icon
DexCom
DXCM
+$9.09M
4
JANX icon
Janux Therapeutics
JANX
+$8.92M
5
BBIO icon
BridgeBio Pharma
BBIO
+$7.53M

Top Sells

Rank Stock Value
1
KELYA icon
Kelly Services Class A
KELYA
+$10.5M
2
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$8.74M
3
ALKS icon
Alkermes
ALKS
+$6.63M
4
KIDS icon
OrthoPediatrics
KIDS
+$5.76M
5
OPCH icon
Option Care Health
OPCH
+$5.68M

Sector Composition

Rank Sector Weight
1 Healthcare 94.39%
2 Miscellaneous 2.95%
3 Industrials 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSP icon
51
Inspire Medical Systems
INSP
$1.78B
– –
-14,000
Closed -$1.87M
KELYA icon
52
Kelly Services Class A
KELYA
$600M
– –
-492,340
Closed -$10.5M
KIDS icon
53
OrthoPediatrics
KIDS
$617M
– –
-200,216
Closed -$5.76M
KZR
54
DELISTED
Kezar Life Sciences
KZR
– –
-5,608
Closed -$33.6K
MDT icon
55
Medtronic
MDT
$117B
– –
-30,000
Closed -$2.36M
OPCH icon
56
Option Care Health
OPCH
$3.58B
– –
-205,000
Closed -$5.68M
PRVA icon
57
Privia Health
PRVA
$2.66B
– –
-96,065
Closed -$1.67M
RLAY icon
58
Relay Therapeutics
RLAY
$4.11B
– –
-385,000
Closed -$2.51M
TXG icon
59
10x Genomics
TXG
$8.02B
– –
-49,021
Closed -$953K
UHS icon
60
Universal Health Services
UHS
$10.1B
– –
-9,373
Closed -$1.73M
LENZ
61
LENZ Therapeutics
LENZ
$161M
– –
-59,542
Closed -$1.03M
FNA
62
DELISTED
Paragon 28, Inc.
FNA
– –
-261,400
Closed -$1.79M
1 2
3

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q3 2024 Portfolio in Review

As of Q3 2024, Prosight Management held 62 positions worth $406M, up 21% from $335M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Prosight Management deployed $62M of net new capital in Q3 2024, opening 16 new positions and adding to 17 existing holdings. Its largest new stake was McKesson: 35,822 shares worth $17.7M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Lakefront Biotherapeutics American Depositary Shares, an estimated $8.74M trimmed.

  • Prosight Management's largest Q3 2024 buy was McKesson: 35,822 shares worth $17.7M.
  • Prosight Management added most to AbCellera Biologics in Q3 2024, an estimated $18.6M increase.
  • Prosight Management's biggest Q3 2024 reduction was Lakefront Biotherapeutics American Depositary Shares, cutting an estimated $8.74M.
  • Prosight Management fully exited Kelly Services Class A in Q3 2024, selling an estimated $10.5M.
  • Prosight Management's ten largest holdings make up 55% of its $406M portfolio in Q3 2024.
  • Prosight Management opened 16 new positions and closed 17 in Q3 2024.
  • Prosight Management's portfolio value rose 21% quarter-over-quarter to $406M.

Based on Prosight Management's 13F filing for Q3 2024, filed 14 Nov 2024.